EP0124363A3 - Photochemical decontamination treatment of whole blood or blood components - Google Patents
Photochemical decontamination treatment of whole blood or blood components Download PDFInfo
- Publication number
- EP0124363A3 EP0124363A3 EP84302845A EP84302845A EP0124363A3 EP 0124363 A3 EP0124363 A3 EP 0124363A3 EP 84302845 A EP84302845 A EP 84302845A EP 84302845 A EP84302845 A EP 84302845A EP 0124363 A3 EP0124363 A3 EP 0124363A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- blood
- decontamination treatment
- whole blood
- photochemical decontamination
- components
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 239000012503 blood component Substances 0.000 title 1
- 238000005202 decontamination Methods 0.000 title 1
- 230000003588 decontaminative effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 230000001766 physiological effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical class C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/10—Ultraviolet radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
- A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Anesthesiology (AREA)
- Developmental Biology & Embryology (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- External Artificial Organs (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT84302845T ATE59145T1 (en) | 1983-05-02 | 1984-04-27 | PHOTOCHEMICAL PURIFICATION TREATMENT OF WHOLE BLOOD OR BLOOD COMPONENTS. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49068183A | 1983-05-02 | 1983-05-02 | |
US490681 | 1983-05-02 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0124363A2 EP0124363A2 (en) | 1984-11-07 |
EP0124363A3 true EP0124363A3 (en) | 1985-07-03 |
EP0124363B1 EP0124363B1 (en) | 1990-12-19 |
Family
ID=23949050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP84302845A Expired - Lifetime EP0124363B1 (en) | 1983-05-02 | 1984-04-27 | Photochemical decontamination treatment of whole blood or blood components |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0124363B1 (en) |
JP (1) | JPS6016930A (en) |
AT (1) | ATE59145T1 (en) |
AU (1) | AU563557B2 (en) |
CA (1) | CA1224622A (en) |
DE (1) | DE3483751D1 (en) |
ZA (1) | ZA843270B (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK507185A (en) * | 1984-11-05 | 1986-05-06 | Du Pont | METHOD OF INACTIVATING HUMAN TUMOR LEUKAEMI VIRUS III |
JPS61275228A (en) * | 1985-03-14 | 1986-12-05 | バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド | Photodynamic inactivity of virus in therapeutical protein composition |
US4789545A (en) * | 1986-03-31 | 1988-12-06 | New York Blood Center, Inc. | Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof |
US4775625A (en) * | 1986-11-21 | 1988-10-04 | The Medical College Of Wisconsin, Inc. | Inactivating enveloped viruses with a merocyanine dye |
US4878891A (en) † | 1987-06-25 | 1989-11-07 | Baylor Research Foundation | Method for eradicating infectious biological contaminants in body tissues |
US5571666A (en) * | 1988-10-28 | 1996-11-05 | Oklahoma Medical Research Foundation | Thiazine dyes used to inactivate HIV in biological fluids |
IL92996A (en) * | 1989-01-10 | 1996-06-18 | Bisaccia Emil | Photoactive compounds as medicaments for the treatment of virus infections and method for production of vaccines |
WO1991006665A1 (en) * | 1989-10-26 | 1991-05-16 | Isaacs Stephen T | Activation compounds and methods for nucleic acid sterilization |
US5503721A (en) | 1991-07-18 | 1996-04-02 | Hri Research, Inc. | Method for photoactivation |
US6187572B1 (en) | 1990-04-16 | 2001-02-13 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants |
US5418130A (en) | 1990-04-16 | 1995-05-23 | Cryopharm Corporation | Method of inactivation of viral and bacterial blood contaminants |
US5516629A (en) | 1990-04-16 | 1996-05-14 | Cryopharm Corporation | Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins |
WO1991016060A1 (en) * | 1990-04-16 | 1991-10-31 | Cryopharm Corporation | Method of inactivation of viral and bacterial blood contaminants |
US5120649A (en) * | 1990-05-15 | 1992-06-09 | New York Blood Center, Inc. | Photodynamic inactivation of viruses in blood cell-containing compositions |
US5232844A (en) * | 1990-05-15 | 1993-08-03 | New York Blood Center | Photodynamic inactivation of viruses in cell-containing compositions |
US5712086A (en) * | 1990-05-15 | 1998-01-27 | New York Blood Center, Inc. | Process for transfusing cell containing fractions sterilized with radiation and a quencher of type I and type II photodynamic reactions |
US5981163A (en) | 1990-05-15 | 1999-11-09 | New York Blood Center, Inc. | Process for the sterilization of biological compositions using irradiation and quenchers of type I and type II photodynamic reactions |
DE4136900C1 (en) * | 1991-11-09 | 1993-07-29 | Schaper & Bruemmer Gmbh & Co Kg, 3320 Salzgitter, De | |
EP0633786B1 (en) * | 1992-01-27 | 2001-08-01 | Baxter International Inc. | Method of inactivation of viral, parasitic and bacterial blood contaminants |
US5288605A (en) * | 1992-03-02 | 1994-02-22 | Steritech, Inc. | Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
CA2141803C (en) * | 1992-08-07 | 2003-06-17 | Lily Lin | Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
US5399719A (en) * | 1993-06-28 | 1995-03-21 | Steritech, Inc. | Compounds for the photodecontamination of pathogens in blood |
US5556993A (en) | 1993-06-28 | 1996-09-17 | Steritech, Inc. | Compounds for the photodecontamination of pathogens in blood |
US6420570B1 (en) | 1993-06-28 | 2002-07-16 | Cerus Corporation | Psoralen compounds |
US6319662B1 (en) | 1993-12-17 | 2001-11-20 | Baxter International Inc. | Method and apparatus for removing viral contaminants from a body fluid |
US6258577B1 (en) | 1998-07-21 | 2001-07-10 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers |
US7186543B1 (en) | 1998-07-21 | 2007-03-06 | Gambro Inc. | Preparation of vaccines using a photosensitizer and light |
US6268120B1 (en) | 1999-10-19 | 2001-07-31 | Gambro, Inc. | Isoalloxazine derivatives to neutralize biological contaminants |
US7648699B2 (en) | 2000-06-02 | 2010-01-19 | Caridianbct Biotechnologies, Llc | Preventing transfusion related complications in a recipient of a blood transfusion |
TW590780B (en) | 2000-06-02 | 2004-06-11 | Gambro Inc | Additive solutions containing riboflavin |
US7985588B2 (en) | 2000-06-02 | 2011-07-26 | Caridianbct Biotechnologies, Llc | Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light |
US9044523B2 (en) | 2000-06-15 | 2015-06-02 | Terumo Bct, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
AU2002366708A1 (en) * | 2001-12-20 | 2003-07-09 | Gambro, Inc. | Preparation of vaccines using photosensitizer and light |
NL2000281C2 (en) | 2005-11-02 | 2007-08-07 | Pfizer Prod Inc | Solid pharmaceutical compositions containing pregabalin. |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3686395A (en) * | 1966-04-06 | 1972-08-22 | Biotest Serum Institut Gmbh | Process for preparation of storage stable hepatitis-free serum |
EP0030358A2 (en) * | 1979-12-11 | 1981-06-17 | Leukocyte Research, Inc. | Apparatus for reducing the functioning lymphocyte population in blood |
EP0047462A2 (en) * | 1980-09-10 | 1982-03-17 | Biotest-Serum-Institut GmbH | Method for the cold-sterilisation of preparations containing blood coagulation factor VIII |
EP0066886A2 (en) * | 1981-06-09 | 1982-12-15 | Lee H. Kronenberg | Inactivated target cells, methods of using same and vaccines and diagnostic kits containing same |
-
1984
- 1984-04-27 DE DE8484302845T patent/DE3483751D1/en not_active Expired - Lifetime
- 1984-04-27 EP EP84302845A patent/EP0124363B1/en not_active Expired - Lifetime
- 1984-04-27 AT AT84302845T patent/ATE59145T1/en not_active IP Right Cessation
- 1984-04-30 AU AU27521/84A patent/AU563557B2/en not_active Expired
- 1984-05-01 JP JP59086273A patent/JPS6016930A/en active Granted
- 1984-05-01 CA CA000453232A patent/CA1224622A/en not_active Expired
- 1984-05-02 ZA ZA843270A patent/ZA843270B/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3686395A (en) * | 1966-04-06 | 1972-08-22 | Biotest Serum Institut Gmbh | Process for preparation of storage stable hepatitis-free serum |
EP0030358A2 (en) * | 1979-12-11 | 1981-06-17 | Leukocyte Research, Inc. | Apparatus for reducing the functioning lymphocyte population in blood |
EP0047462A2 (en) * | 1980-09-10 | 1982-03-17 | Biotest-Serum-Institut GmbH | Method for the cold-sterilisation of preparations containing blood coagulation factor VIII |
EP0066886A2 (en) * | 1981-06-09 | 1982-12-15 | Lee H. Kronenberg | Inactivated target cells, methods of using same and vaccines and diagnostic kits containing same |
Non-Patent Citations (2)
Title |
---|
CHEMICAL ABSTRACTS, Vol. 87, No. 11, 8 September 12, 1977, page 98, abstract no. 78962f, Columbus, Ohio (US) J.E. HEARST et al.: "The photoinactivation of an RNA animal virus, vesicular stomatiti virus, with the aid of newly synthesized psoralen derivatives"; & Nucleic Acids Res. 1977, 4 (5), 1339-47 * |
EXPERIENTIA, Vol. 21, No. 1, January 15, 1965, pages 22-24, Birkhauser Verlag, Basel. (CH) L. MUSAJO et al.: "Photosensitizing furocoumarins: interaction with DNA and photo-inactivation of DNA containing viruses" * |
Also Published As
Publication number | Publication date |
---|---|
AU2752184A (en) | 1984-11-08 |
JPS6016930A (en) | 1985-01-28 |
ATE59145T1 (en) | 1991-01-15 |
AU563557B2 (en) | 1987-07-16 |
ZA843270B (en) | 1984-11-28 |
CA1224622A (en) | 1987-07-28 |
EP0124363B1 (en) | 1990-12-19 |
JPH0572366B2 (en) | 1993-10-12 |
DE3483751D1 (en) | 1991-01-31 |
EP0124363A2 (en) | 1984-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA843270B (en) | Photochemical decontamination treatment of whole blood or blood components | |
DE10199020I1 (en) | Galanthamine or its analogues for the treatment of Alzheimer's disease | |
ATA380384A (en) | USE OF SOLAR FILTERS FOR STABILIZING AND IMPROVING THE SKIN COMPATIBILITY OF PREPARATIONS CONTAINING BENZOYL PEROXYDE FOR LOCAL ACNE TREATMENT | |
DE3770190D1 (en) | LIGHTING ARRANGEMENT FOR A SYSTEM FOR TREATING A PATIENT BY PHOTOACTIVATION. | |
ATE262900T1 (en) | THERAPEUTIC AND FOOD COMPOSITIONS CONTAINING ESSENTIAL FATTY ACIDS AND BIOACTIVE DISULPHIDES | |
DE3869230D1 (en) | METHOD FOR PRODUCING A SOLUTION OF HIGH SPECIFIC VOLUME ACTIVITY FROM A PROTEIN WITH TISSUE PLASMINOGEN ACTIVATOR (T-PA) ACTIVITY, SOLUTION, CONTAINING PROTEIN WITH T-PA ACTIVITY AND USE OF THE SOLUTION AND IN THE HUMAN VITALIZE. | |
DE68910175D1 (en) | Adsorber module and adsorber apparatus for the treatment of whole blood. | |
NO913129D0 (en) | NEW TROMBOLYTIC AGENT. | |
DE58902451D1 (en) | (S) -EMOPAMIL FOR USE IN TREATING MIGRAENE. | |
AU4877285A (en) | Sterilization of adsorbent and column having improved storability including sterilized adsorbent for use in extracorporeal circulation treatment | |
ATE25969T1 (en) | 1,7-DIPHENYL-3-METHYLAZA-7-CYAN-8-METHYL-NONANE FOR USE IN COMBATING DISEASE. | |
DE3674619D1 (en) | COMPOSITION FOR BATHS BASED ON PSORALEN IN THE TREATMENT OF PSORIASIS. | |
DE3764697D1 (en) | MEDICAL PREPARATION CONTAINING T-PA AND THEIR USE. | |
NZ220495A (en) | A2a cyclopeptan-2-ones carrier containing methotrexate compositions | |
DE3872871D1 (en) | USE OF METALLOPORPHYRIN TO REVERSE THE TOXIC EFFECT OF TUMOR THERAPY. | |
CA2015315A1 (en) | Improved method of blood component decontamination by glucose addition and post-decontamination gassing | |
DE3767175D1 (en) | THERAPEUTIC COMPOSITIONS BASED ON 3-ALKOXYFLAVONES AND DERIVATIVES OF 3-ALKOXYFLAVONES. | |
ATE75938T1 (en) | THERAPEUTIC AGENT CONTAINING ENANTIOMERS OF PROPAFENONE. | |
DE3261741D1 (en) | Treatment of poultry carcasses | |
GB2086724B (en) | Blood circulation composition containing gelatin and/or solubilized collagen | |
ATE136776T1 (en) | USE OF HEPTASTIGMINE TO TREAT CEREBRAL ICTUS | |
ZA858104B (en) | Sterilization of adsorbent and column having improved storability including sterilized adsorbent for use in extracorporeal circulation treatment | |
DE3672196D1 (en) | GELATINE AND GLYZINE-BASED FORMULATION FOR TREATING THE DRYNESS OF THE SKIN. | |
CY1794A (en) | New use of 1,4-dihydropyridine derivatives | |
ATE88090T1 (en) | USE OF ACETYL-D-CARNITINE IN THE THERAPEUTIC TREATMENT OF GLAUCOMA. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
17P | Request for examination filed |
Effective date: 19851017 |
|
17Q | First examination report despatched |
Effective date: 19871223 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: DIAMOND SCIENTIFIC CO. |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
REF | Corresponds to: |
Ref document number: 59145 Country of ref document: AT Date of ref document: 19910115 Kind code of ref document: T |
|
REF | Corresponds to: |
Ref document number: 3483751 Country of ref document: DE Date of ref document: 19910131 |
|
ITF | It: translation for a ep patent filed |
Owner name: MODIANO & ASSOCIATI S.R.L. |
|
ET | Fr: translation filed | ||
ITTA | It: last paid annual fee | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
ITPR | It: changes in ownership of a european patent |
Owner name: CESSIONE;MILES INC. |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: MILES INC. |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
NLS | Nl: assignments of ep-patents |
Owner name: MILES INC. TE PITTSBURGH, PENNSYLVANIE, VER. ST. V |
|
EPTA | Lu: last paid annual fee | ||
EAL | Se: european patent in force in sweden |
Ref document number: 84302845.7 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20030402 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20030403 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20030418 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20030422 Year of fee payment: 20 Ref country code: CH Payment date: 20030422 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20030423 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20030430 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20030502 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20030514 Year of fee payment: 20 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20040426 Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20040426 Ref country code: CH Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20040426 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20040427 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040427 Ref country code: AT Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20040427 |
|
BE20 | Be: patent expired |
Owner name: *MILES INC. Effective date: 20040427 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
EUG | Se: european patent has lapsed | ||
NLV7 | Nl: ceased due to reaching the maximum lifetime of a patent |
Effective date: 20040427 |